2022 Q4 Form 10-Q Financial Statement

#000149315222031344 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$29.64K -$1.179K
YoY Change
Interest Expense $126.9K
YoY Change
% of Operating Profit
Other Income/Expense, Net $126.9K -$62.50K
YoY Change
Pretax Income $97.25K -$63.68K
YoY Change
Income Tax $24.39K
% Of Pretax Income 25.08%
Net Earnings $72.86K -$63.68K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share $0.01
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 14.63M shares 5.048M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $546.2K $632.4K $82.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $6.066M
Prepaid Expenses $9.082K $159.5K
Receivables
Other Receivables $209.8K
Total Short-Term Assets $711.3K $791.9K
YoY Change 2745.17%
LONG-TERM ASSETS
Property, Plant & Equipment $570.8K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $117.3M $116.3M
YoY Change 215059.98%
TOTAL ASSETS
Total Short-Term Assets $711.3K $791.9K
Total Long-Term Assets $117.3M $116.3M
Total Assets $118.0M $117.1M
YoY Change 148302.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $486.8K
YoY Change
Accrued Expenses $153.4K $19.08K
YoY Change
Deferred Revenue $14.17M
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $681.3K $392.0K
YoY Change 1138.72%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $681.3K $392.0K
Total Long-Term Liabilities
Total Liabilities $4.706M $4.417M
YoY Change 8456.9%
SHAREHOLDERS EQUITY
Retained Earnings -$3.538M -$3.431M
YoY Change 721896.12%
Common Stock $313.00 $313.00
YoY Change 8.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.537M -$3.430M $22.66K
YoY Change
Total Liabilities & Shareholders Equity $118.0M $117.1M
YoY Change 148302.71%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income $72.86K -$63.68K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001922858
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
EFHTU Increase Decrease In Prepaid Insurance Short Term
IncreaseDecreaseInPrepaidInsuranceShortTerm
usd
EFHTU Increase Decrease In Prepaid Insurance Long Term
IncreaseDecreaseInPrepaidInsuranceLongTerm
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
EFHTU Noncash Accretion Of Class Common Stock To Redemption Value
NoncashAccretionOfClassCommonStockToRedemptionValue
usd
EFHTU Noncash Deferred Underwriting Fee Payable
NoncashDeferredUnderwritingFeePayable
usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41497
dei Entity Registrant Name
EntityRegistrantName
EF HUTTON ACQUISITION CORPORATION I
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2559175
dei Entity Address Address Line1
EntityAddressAddressLine1
24 Shipyard Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Hingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02043
dei City Area Code
CityAreaCode
(929)
dei Local Phone Number
LocalPhoneNumber
528-0767
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14632500 shares
CY2022Q3 us-gaap Cash
Cash
632392 usd
CY2021Q4 us-gaap Cash
Cash
25000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
159497 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
791889 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
25000 usd
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
54510 usd
CY2022Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
68033 usd
CY2022Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
116276881 usd
CY2022Q3 us-gaap Assets
Assets
117136803 usd
CY2021Q4 us-gaap Assets
Assets
79510 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19078 usd
CY2022Q3 EFHTU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
328867 usd
CY2021Q4 EFHTU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
55000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
19700 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
24385 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
392030 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55000 usd
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4025000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
4417030 usd
CY2021Q4 us-gaap Liabilities
Liabilities
55000 usd
CY2022Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11500000 shares
CY2022Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.10
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116150000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3132500 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3132500 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2875000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2875000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
313 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
288 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24712 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3430540 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-490 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3430227 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117136803 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79510 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29636 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
31483 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
490 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29636 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-31483 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-490 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
126881 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
126881 usd
us-gaap Share Based Compensation
ShareBasedCompensation
62500 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
126881 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
64381 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
97245 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32898 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-490 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24385 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24385 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
72860 usd
us-gaap Net Income Loss
NetIncomeLoss
8513 usd
us-gaap Net Income Loss
NetIncomeLoss
-490 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5047582 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3607152 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2488152 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-668 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
23842 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-63679 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
22663 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
257500 shares
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2575000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1016600 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3626296 usd
CY2022Q3 EFHTU Adjustments To Additional Paid In Capital Fair Value Of Rights Included In Public Units
AdjustmentsToAdditionalPaidInCapitalFairValueOfRightsIncludedInPublicUnits
1329317 usd
CY2022Q3 EFHTU Adjustments To Additional Paid In Capital Allocated Value Of Transaction Costs To Common Stock
AdjustmentsToAdditionalPaidInCapitalAllocatedValueOfTransactionCostsToCommonStock
-272626 usd
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
11800337 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
72860 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3430227 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-490 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
24510 usd
us-gaap Net Income Loss
NetIncomeLoss
8513 usd
us-gaap Net Income Loss
NetIncomeLoss
-490 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
126881 usd
us-gaap Share Based Compensation
ShareBasedCompensation
62500 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3497 usd
EFHTU Increase Decrease In Prepaid Insurance Short Term
IncreaseDecreaseInPrepaidInsuranceShortTerm
156000 usd
EFHTU Increase Decrease In Prepaid Insurance Long Term
IncreaseDecreaseInPrepaidInsuranceLongTerm
68033 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18588 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
490 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
24385 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-240425 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
116150000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116150000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
115000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2575000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19700 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
596883 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
116997817 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
607392 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
632392 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25000 usd
EFHTU Noncash Offering Costs Included In Accrued Offering Costs
NoncashOfferingCostsIncludedInAccruedOfferingCosts
328867 usd
EFHTU Noncash Offering Costs Included In Accrued Offering Costs
NoncashOfferingCostsIncludedInAccruedOfferingCosts
54510 usd
EFHTU Noncash Accretion Of Class Common Stock To Redemption Value
NoncashAccretionOfClassCommonStockToRedemptionValue
11800337 usd
EFHTU Noncash Deferred Underwriting Fee Payable
NoncashDeferredUnderwritingFeePayable
4025000 usd
CY2022Q3 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
115000000 usd
EFHTU Transaction Costs Amount
TransactionCostsAmount
4950750 usd
CY2022Q3 EFHTU Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
4025000 usd
CY2021Q2 EFHTU Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
925750 usd
CY2022Q3 EFHTU Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 usd
CY2022Q3 EFHTU Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
EFHTU Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 usd
CY2022Q3 us-gaap Share Price
SharePrice
10.10
CY2022Q3 EFHTU Minimum Tangible Assets For Business Combination
MinimumTangibleAssetsForBusinessCombination
5000001 usd
EFHTU Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 usd
EFHTU Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zJezOZapKspa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zf3MUxhQvSHa">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Cash
Cash
632392 usd
CY2021Q4 us-gaap Cash
Cash
25000 usd
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
0 usd
EFHTU Proceeds From Issuance Of Allocated To Public Rights
ProceedsFromIssuanceOfAllocatedToPublicRights
1329317 usd
EFHTU Issuance Costs Allocated To Common Stock
IssuanceCostsAllocatedToCommonStock
8304420 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
11800337 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
115000000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1016600 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_z9Swh9Owq9Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zvjIinveI3ef">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zmjKEw0thID" title="Federal deposit insurance corporation coverage, amount">250,000</span>. The Company has not experienced losses on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2508 pure
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.7412 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116150000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
72860 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8513 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-490 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5047582 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3607152 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2488152 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3132500 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3132500 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2875000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2875000 shares
CY2022Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11500000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11757500 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
11757500 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd

Files In Submission

Name View Source Status
0001493152-22-031344-index-headers.html Edgar Link pending
0001493152-22-031344-index.html Edgar Link pending
0001493152-22-031344.txt Edgar Link pending
0001493152-22-031344-xbrl.zip Edgar Link pending
efhtu-20220930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
efhtu-20220930_def.xml Edgar Link unprocessable
efhtu-20220930_lab.xml Edgar Link unprocessable
efhtu-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
efhtu-20220930_cal.xml Edgar Link unprocessable